MRD / Regn No. : SG001524 Date : 30/06/2026
Patient Name : Abdul Rahaman Mallick Age & Gender : 51 Yrs. / Male
Contact No. : 7407985116 UHID :
Ht / Wt / BMI : 163 / 68 / 25.59 BP S / BP D : 109 / 75
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (03/Aug/2020) | DYSLIPIDEMIA (03/Aug/2023) |
Salient Investigations : TGL TRIGLYCERIDE: 371 mg/dL | CREATININE: 0.84 | EGFR EGLOMERULAR FILTRATION RATE: 102.53 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 108 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 24 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 122 mg/dL | ALT ALANINE AMINOTRANSFERASE: 36 IU/L
S# Generic (Trade) Name Route Dosage Usage Duration
1 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN (10MG) + METFORMIN (1000MG) + SITAGLIPTIN (100MG)
GLUXIT TRIO ER
PO 1-0-0 BEFORE BREAKFAST
2 TABLET ACARBOSE 25 MG
GLUCOBAY 25 MG
Medicine For DIABETES
PO 0-1-0 BEFORE LUNCH
TILL NEXT VISIT
TAKE WITH FIRST BITE OF FOOD. TAKE IN MORNING FIRST WEEK THEN MORNING AND AFTERNOON FROM SECOND WEEK. MAY CAUSE FLATULENCE
3 ANTIHYPERGLYCEMIC GLICLAZIDE XR 60 MG
SECGLY XR 60 MG
PO 1-0-0 BEFORE BREAKFAST
4 TABLET ROSUVASTATIN 20 MG
STATEZE R 20
PO 0-0-1 BEFORE DINNER
TILL NEXT VISIT
5 CAPSULE DOCOSAHEXAENOIC ACID-120MG+EICOSAPENTAENOIC ACID-180MG
TRIOMEGA
PO 1-1-1 BEFORE BEFORE BREAKFAST, LUNCH, AND DINNER
TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 30/Dec/2026
Tests Suggested For Next Visit : HBA1C-HPLC METHOD,RETINA CHECK UP,CREATININE,LIPID PROFILE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: